Latest filings (excl ownership)
10-K
2023 FY
Annual report
25 Mar 24
8-K
Entry into a Material Definitive Agreement
14 Mar 24
8-K
Entry into a Material Definitive Agreement
14 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8 Mar 24
8-K
Completion of Acquisition or Disposition of Assets
15 Feb 24
8-K
Other Events
9 Feb 24
S-8
Registration of securities for employees
6 Feb 24
S-8
Registration of securities for employees
6 Feb 24
8-K
Other Events
30 Jan 24
8-K
Other Events
8 Jan 24
8-K
PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split
5 Dec 23
8-K
PAVmed Provides Business Update and Third Quarter Financial Results
14 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Entry into a Material Definitive Agreement
18 Oct 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Other Events
28 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
21 Jun 23
8-K
Unregistered Sales of Equity Securities
6 Jun 23
424B5
Prospectus supplement for primary offering
30 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
DEF 14A
Definitive proxy
1 May 23
DEFA14A
Additional proxy soliciting materials
1 May 23
PRE 14A
Preliminary proxy
20 Apr 23
8-K
Regulation FD Disclosure
3 Apr 23
8-K
Submission of Matters to a Vote of Security Holders
31 Mar 23
8-K
Entry into a Material Definitive Agreement
24 Mar 23
8-K
PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2022 Financial Results
15 Mar 23
8-K
Entry into a Material Definitive Agreement
14 Mar 23
10-K
2022 FY
Annual report
13 Mar 23
8-K
Entry into a Material Definitive Agreement
13 Mar 23
DEF 14A
Definitive proxy
21 Feb 23
8-K
Termination of a Material Definitive Agreement
17 Feb 23
8-K
Regulation FD Disclosure
16 Feb 23
S-8
Registration of securities for employees
10 Feb 23
S-8
Registration of securities for employees
10 Feb 23
PRE 14A
Preliminary proxy
8 Feb 23
8-K
PAVmed and Lucid Diagnostics Provide Strategic Business Update
18 Jan 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
30 Dec 22
8-K
Other Events
2 Dec 22
8-K
PAVmed Provides Business Update and Third Quarter 2022 Financial Results
15 Nov 22
Latest ownership filings
4
Timothy E Baxter
23 Feb 24
4
Debra White
23 Feb 24
4
Ronald M Sparks
23 Feb 24
4
Joan B Harvey
23 Feb 24
4
Michael J Glennon
23 Feb 24
4
James L Cox
23 Feb 24
4
Lucid Diagnostics Inc.
20 Feb 24
SC 13D/A
Lucid Diagnostics Inc.
20 Feb 24
SC 13G
Ayrton Capital LLC
14 Feb 24
SC 13D/A
Lucid Diagnostics Inc.
2 Feb 24
4
Lucid Diagnostics Inc.
30 Jan 24
4
Shaun O'Neil
1 May 23
3/A
Shaun O'Neil
1 May 23
4/A
Lucid Diagnostics Inc.
13 Apr 23
4
Ronald M Sparks
2 Feb 23
4
Debra White
2 Feb 23
4
Joan B Harvey
2 Feb 23
4
Michael J Glennon
2 Feb 23
4
James L Cox
2 Feb 23
4
Timothy E Baxter
2 Feb 23
4
Michael J Glennon
7 Dec 22
4
Lucid Diagnostics Inc.
2 Dec 22
SC 13D/A
Lucid Diagnostics Inc.
2 Dec 22
SC 13G
BlackRock Inc.
8 Jul 22
4
Michael Adam Gordon
9 Jun 22
3
Michael Adam Gordon
8 Jun 22
4
DENNIS M MCGRATH
11 Apr 22
4
Lishan Aklog
11 Apr 22
4
Timothy E Baxter
1 Mar 22
4
Timothy E Baxter
1 Mar 22
3
Timothy E Baxter
1 Mar 22
4
Shaun O'Neil
24 Feb 22
3
Shaun O'Neil
24 Feb 22
4
Michael J Glennon
23 Feb 22
4
Brian J. DeGuzman
23 Feb 22
4
Debra White
23 Feb 22
4
James L Cox
23 Feb 22
4
Ronald M Sparks
23 Feb 22
4
DENNIS M MCGRATH
23 Feb 22
4
Lishan Aklog
23 Feb 22